Conjugation Chemistry Markedly Impacts Toxicity and Biodistribution of Targeted Nanoparticles, Mediated by Complement Activation
Advanced Materials · 2025-02 · 37 (5)
DOI: 10.1002/adma.202409945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 11.12.2024. Verfasst von Michael H Zaleski und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Pharmacology and Translational Therapeutics, The Perelman School of Medicine, University of Pennsylvania, 421 Curie Blvd., 354 …. Hauptthemen laut MEDLINE: Complement Activation, Nanoparticles. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Foundation for the National Institutes of Health, NIAID NIH HHS.
Abstract (Originalsprache)
Conjugation chemistries are a major enabling technology for the development of drug delivery systems, from antibody‐drug conjugates to antibody‐targeted lipid nanoparticles inspired by the success of the COVID‐19 vaccine. However, here it is shown that for antibody‐targeted nanoparticles, the most popular conjugation chemistries directly participate in the activation of the complement cascade of plasma proteins. Their activation of complement leads to large changes in the biodistribution of nanoparticles (up to 140‐fold increased uptake into phagocytes of the lungs) and multiple toxicities, including a 50% drop in platelet count. It is founded that the mechanism of complement activation varies dramatically between different conjugation chemistries. Dibenzocyclooctyne, a commonly used click‐chemistry, caused aggregation of conjugated antibodies, but only on the surface of nanoparticles (not in bulk solution). By contrast, thiol‐maleimide chemistry do not activate complement via its effects on antibodies, but rather because free maleimide bonded to albumin in plasma, and clustered albumin is then attacked by complement. Using these mechanistic insights, solutions are engineered that reduced the activation of complement for each class of conjugation chemistry. These results highlight that while conjugation chemistry is essential for the future of nanomedicine, it is not innocuous and must be designed with opsonins like complement in mind.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Systems Pharmacology and Translational Therapeutics, The Perelman School of Medicine, University of Pennsylvania, 421 Curie Blvd., 354 BRB II/III, Philadelphia, PA, 19104, USA.
- Department of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA, 19104, USA.
ORCID-Profile: Michael H Zaleski, Liam S Chase, Elizabeth D Hood, Jia Nong, Jacob S Brenner
Förderung
- NHLBI NIH HHS
- Foundation for the National Institutes of Health
- NIAID NIH HHS
- NINDS NIH HHS
- Pennsylvania Department of Health
- NIGMS NIH HHS
- Commonwealth Universal Research Enhancement (CARES) Program
Zitieren
APA
Zaleski, M. H., Chase, L. S., Hood, E. D., Wang, Z., Nong, J., Espy, C. L., Zamora, M. E., Wu, J., Morrell, L. J., Muzykantov, V. R., Myerson, J. W., & Brenner, J. S. (2025). Conjugation Chemistry Markedly Impacts Toxicity and Biodistribution of Targeted Nanoparticles, Mediated by Complement Activation. Advanced Materials, 37(5). https://doi.org/10.1002/adma.202409945
Vancouver
Zaleski MH, Chase LS, Hood ED, Wang Z, Nong J, Espy CL, et al. Conjugation Chemistry Markedly Impacts Toxicity and Biodistribution of Targeted Nanoparticles, Mediated by Complement Activation. Advanced Materials. 2025;37(5). doi:10.1002/adma.202409945
BibTeX
@article{Zaleski2025,
author = {Zaleski, Michael H and Chase, Liam S and Hood, Elizabeth D and Wang, Zhicheng and Nong, Jia and Espy, Carolann L and Zamora, Marco E and Wu, Jichuan and Morrell, Lianne J and Muzykantov, Vladimir R and Myerson, Jacob W and Brenner, Jacob S},
title = {Conjugation Chemistry Markedly Impacts Toxicity and Biodistribution of Targeted Nanoparticles, Mediated by Complement Activation},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {5},
doi = {10.1002/adma.202409945}
}
EUVIMED